Similar articles

• Contributions to the treatment of cancer of the head and neck. Regional antimetabolite infusion.

  OETTGEN HF. OETTGEN HF. East Afr Med J. 1961 Nov;38:493-500. East Afr Med J. 1961. PMID: 14481193 No abstract available.
• Contributions to the treatment of cancer of the head and neck. Improved methods of administration of chemotherapeutic agents.

  DUFF JK. DUFF JK. East Afr Med J. 1961 Nov;38:502-4. East Afr Med J. 1961. PMID: 13888226 No abstract available.
• Contributions to the treatment of cancer of the head and neck. The assessment of therapeutic results.

  CLIFFORD P. CLIFFORD P. East Afr Med J. 1961 Nov;38:504-9. East Afr Med J. 1961. PMID: 13879946 No abstract available.
• Head and Neck Masses.

  Yan K, Agrawal N, Gooi Z. Yan K, et al. Med Clin North Am. 2018 Nov;102(6):1013-1025. doi: 10.1016/j.mcna.2018.06.012. Epub 2018 Sep 20. Med Clin North Am. 2018. PMID: 30342605 Review.
• Monoclonal antibodies (Mabs) in head and neck cancer.

  Poliquin JF, Filion LG. Poliquin JF, et al. J Otolaryngol. 1986 Oct;15(5):289-92. J Otolaryngol. 1986. PMID: 3534285 Review.